Main Quotes Calendar Forum
flag

FX.co ★ Organovo Appoints Norman Staskey As CFO

back back next
typeContent_19130:::2025-01-06T21:15:00

Organovo Appoints Norman Staskey As CFO

Organovo Holdings, Inc. (ONVO), a clinical-stage biotechnology company specializing in pioneering treatments for inflammatory bowel disease, announced on Monday the appointment of Norman Staskey as its new Chief Financial Officer (CFO). Staskey brings experience from Danforth Advisors, where he has been delivering CFO services since 2021 to clients such as Azitra, Inc. As of the latest update, ONVO's stock is experiencing a rise, trading at $0.48, which marks an increase of 7.15 percent or $0.032 on the Nasdaq.

Share this article:
back back next
loader...
all-was_read__icon
You have watched all the best publications
presently.
We are already looking for something interesting for you...
all-was_read__star
Recently published:
loader...
More recent publications...